- Home
- STVN vs CROX Comparison
STVN vs CROX Comparison
Compare STVN & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STVN
- CROX
- Stock Information
- Founded
- STVN 1949
- CROX 1999
- Country
- STVN Italy
- CROX United States
- Employees
- STVN N/A
- CROX N/A
- Industry
- STVN Containers/Packaging
- CROX Shoe Manufacturing
- Sector
- STVN Consumer Discretionary
- CROX Consumer Discretionary
- Exchange
- STVN Nasdaq
- CROX Nasdaq
- Market Cap
- STVN 6.2B
- CROX 5.6B
- IPO Year
- STVN 2021
- CROX 2006
- Fundamental
- Price
- STVN $22.96
- CROX $87.43
- Analyst Decision
- STVN Buy
- CROX Buy
- Analyst Count
- STVN 4
- CROX 12
- Target Price
- STVN $25.13
- CROX $105.18
- AVG Volume (30 Days)
- STVN 341.4K
- CROX 3.0M
- Earning Date
- STVN 08-05-2025
- CROX 08-07-2025
- Dividend Yield
- STVN 0.27%
- CROX N/A
- EPS Growth
- STVN 6.78
- CROX N/A
- EPS
- STVN 0.57
- CROX 4.12
- Revenue
- STVN $1,344,798,591.00
- CROX $4,138,679,000.00
- Revenue This Year
- STVN $8.24
- CROX N/A
- Revenue Next Year
- STVN $10.38
- CROX $0.71
- P/E Ratio
- STVN $40.05
- CROX $21.14
- Revenue Growth
- STVN 5.28
- CROX 2.04
- 52 Week Low
- STVN $17.12
- CROX $73.76
- 52 Week High
- STVN $28.00
- CROX $151.13
- Technical
- Relative Strength Index (RSI)
- STVN 47.98
- CROX 46.12
- Support Level
- STVN $21.51
- CROX $85.34
- Resistance Level
- STVN $23.72
- CROX $87.12
- Average True Range (ATR)
- STVN 0.84
- CROX 2.39
- MACD
- STVN 0.09
- CROX 1.04
- Stochastic Oscillator
- STVN 65.77
- CROX 99.92
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.